Genmab — Maj 2015
-
Så starter Lebowitz
-
dara kunne potentielt være immunooncology drug ?
-
havana vi havde ikke forventet der ville komme noget der ville flytte kursen. men nogen gange er det nok bare at vide at det kører som det skal og dara har høj prioritet
-
Det eneste der bekymrede mig var at de sagde de havde en masse "Next in class" produkter indenfor MM som ville komme efter Dara.
-
Omvendt skal nye produkter jo virkelig være gode for at vælte Dara når først dara har sat sig på markedet. Så skal de kunne slå dara head to head
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind